| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 2.09e-04 | 86 | 27 | 3 | GO:0004197 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 2.36e-04 | 17 | 27 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.47e-04 | 430 | 27 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.65e-03 | 654 | 27 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 2.16e-03 | 192 | 27 | 3 | GO:0008234 | |
| Domain | Calpain_III | 1.32e-04 | 12 | 27 | 2 | IPR022683 | |
| Domain | calpain_III | 1.32e-04 | 12 | 27 | 2 | SM00720 | |
| Domain | C2_III | 1.32e-04 | 12 | 27 | 2 | IPR033883 | |
| Domain | Calpain_domain_III | 1.55e-04 | 13 | 27 | 2 | IPR022682 | |
| Domain | Calpain_III | 1.55e-04 | 13 | 27 | 2 | PF01067 | |
| Domain | Calpain_cysteine_protease | 1.81e-04 | 14 | 27 | 2 | IPR022684 | |
| Domain | CysPc | 2.09e-04 | 15 | 27 | 2 | SM00230 | |
| Domain | CALPAIN_CAT | 2.09e-04 | 15 | 27 | 2 | PS50203 | |
| Domain | Peptidase_C2_calpain_cat | 2.09e-04 | 15 | 27 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 2.09e-04 | 15 | 27 | 2 | PF00648 | |
| Domain | THIOL_PROTEASE_CYS | 6.40e-04 | 26 | 27 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 6.91e-04 | 27 | 27 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 6.91e-04 | 27 | 27 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 7.43e-04 | 28 | 27 | 2 | IPR000169 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.52e-05 | 300 | 16 | 5 | M610 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.68e-04 | 258 | 16 | 4 | MM14572 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.92e-04 | 102 | 16 | 3 | MM15830 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.67e-04 | 114 | 16 | 3 | MM14571 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.17e-04 | 27 | 16 | 2 | M27217 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.88e-04 | 140 | 16 | 3 | M587 | |
| Pathway | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | 8.73e-04 | 39 | 16 | 2 | M3871 | |
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 14981075 | ||
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 10964513 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 34630166 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 9396712 | ||
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 1.62e-05 | 8 | 27 | 2 | 9885250 | |
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 8698813 | ||
| Pubmed | 3.81e-05 | 12 | 27 | 2 | 18292603 | ||
| Pubmed | Furin, a transcriptional target of NKX2-5, has an essential role in heart development and function. | 4.50e-05 | 13 | 27 | 2 | 30840660 | |
| Pubmed | Isl1 Controls Patterning and Mineralization of Enamel in the Continuously Renewing Mouse Incisor. | 1.09e-04 | 20 | 27 | 2 | 28650075 | |
| Pubmed | An endoplasmic reticulum stress regulator, Tmbim6, modulates secretory stage of mice molar. | 1.09e-04 | 20 | 27 | 2 | 30963569 | |
| Pubmed | Embryonic lethality in mice lacking Trim59 due to impaired gastrulation development. | 1.45e-04 | 23 | 27 | 2 | 29467473 | |
| Pubmed | Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. | 2.01e-04 | 27 | 27 | 2 | 36899856 | |
| Pubmed | 2.33e-04 | 29 | 27 | 2 | 17339028 | ||
| Pubmed | 3.02e-04 | 33 | 27 | 2 | 36964131 | ||
| Pubmed | SIK2 orchestrates actin-dependent host response upon Salmonella infection. | 6.95e-04 | 50 | 27 | 2 | 33947818 | |
| Cytoband | 12p13.33 | 5.66e-05 | 19 | 27 | 2 | 12p13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.15e-03 | 797 | 27 | 4 | chr19p13 | |
| Cytoband | 19p13.2 | 8.01e-03 | 229 | 27 | 2 | 19p13.2 | |
| Cytoband | 19p13.3 | 8.56e-03 | 237 | 27 | 2 | 19p13.3 | |
| GeneFamily | C2 domain containing|Calpains | 7.66e-05 | 15 | 16 | 2 | 975 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.14e-06 | 200 | 27 | 4 | 7668ae7ed550583ab59e419c5c9bb9f2d7e8e0d5 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)----L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.14e-06 | 200 | 27 | 4 | 44f0278cb0e4ffcda4af3719d7f5819a10929b9f | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.14e-06 | 200 | 27 | 4 | 23da7790e09575b2ca909ed16806b44223bf1017 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.14e-06 | 200 | 27 | 4 | 91f3df1c5a661ff703835f58a35cee93f18eb15c | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.14e-06 | 200 | 27 | 4 | 2e2b1d252972b702ade25526ec8461bf613d81b0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.34e-05 | 141 | 27 | 3 | b2857b73fd754b879b922c7720b5ac3024976822 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 166 | 27 | 3 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 169 | 27 | 3 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-8|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.43e-04 | 169 | 27 | 3 | 2ce1a4183cd5222199fd7b61d5f9479c0ce37478 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 169 | 27 | 3 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 766e712e4db440468a32971459c1d3354add611f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-04 | 173 | 27 | 3 | 4ec147479b359cce1975d57a50ee1437a0e1e663 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 40ef91afb366e87b5ba2951d2578ebfe04d042c0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 176 | 27 | 3 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 177 | 27 | 3 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 178 | 27 | 3 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 184 | 27 | 3 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TEM|Control / Disease, Lineage and Cell Type | 1.92e-04 | 187 | 27 | 3 | 7fdff970a9397305d0b8194c00a043cc69dcca12 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.98e-04 | 189 | 27 | 3 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.08e-04 | 192 | 27 | 3 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | critical-Lymphoid-CTL|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.08e-04 | 192 | 27 | 3 | 8c83050c1578d43ca0398ff920f30ea63f092a83 | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.08e-04 | 192 | 27 | 3 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-04 | 193 | 27 | 3 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 193 | 27 | 3 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 193 | 27 | 3 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | IIH-CD8|IIH / Condition, Cell_class and T cell subcluster | 2.11e-04 | 193 | 27 | 3 | 343ac8c6dc6d7c7a944a14de65f1d4ea3dfafe86 | |
| ToppCell | Control-MAIT|Control / Disease condition and Cell class | 2.14e-04 | 194 | 27 | 3 | ed99f8bff6766795fc396990604366f49ff58181 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 2.17e-04 | 195 | 27 | 3 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-04 | 196 | 27 | 3 | ae9bf04531b9bda819608d90736c4405a6c3df41 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.20e-04 | 196 | 27 | 3 | aec2b11a6048048820271266fdc8b8d806da9993 | |
| ToppCell | Healthy_donor-CD8+_Tem|World / disease group, cell group and cell class (v2) | 2.20e-04 | 196 | 27 | 3 | b04684d319d0c462862677d0f956a389bffef535 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.20e-04 | 196 | 27 | 3 | aa0dc04f94a575cd442ee473b75a4f54268e4105 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-04 | 196 | 27 | 3 | 502834a16d5ada93af7ab9af0c3dc652086964bd | |
| ToppCell | Control-Lymphoid_T/NK-gd_T|Control / Disease group, lineage and cell class | 2.20e-04 | 196 | 27 | 3 | 98b11aada6bc5d928ef618573dc912d4d74a1092 | |
| ToppCell | Healthy/Control-gd_T|World / Disease group and Cell class | 2.20e-04 | 196 | 27 | 3 | b982c84552e7efbff2be861f0f569f40804f5d88 | |
| ToppCell | normal_Lung-T/NK_cells-NK|normal_Lung / Location, Cell class and cell subclass | 2.24e-04 | 197 | 27 | 3 | 6045a05a5f1073d683806eb46a3fa98358414625 | |
| ToppCell | Influenza_Severe-NK|Influenza_Severe / Disease group and Cell class | 2.24e-04 | 197 | 27 | 3 | d0f58ee4c02573d214deb210bb7efd3d6118f267 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.27e-04 | 198 | 27 | 3 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | severe_influenza-NK|severe_influenza / disease group, cell group and cell class (v2) | 2.27e-04 | 198 | 27 | 3 | d431beb870ff5e165d98febfb27049d729e37dc8 | |
| ToppCell | Healthy_donor-gd_T|World / disease group, cell group and cell class (v2) | 2.27e-04 | 198 | 27 | 3 | 0c3475936f148f2c026501c61b43bcb94d320c48 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | 0dc5806714fb3d3983e9d19fa7a108e93a8090ed | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK|Influenza_Severe / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 04ac14414d550b14dc46d682e7af9dd43982211a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-gd_T|Control / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 88e502c141bbb73e62aa5830d24bd645376e5f3a | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-MAIT|Int-URO / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 043c18e79a969e37bbff86443e553ac09fe33f84 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK|Influenza_Severe / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | b3df52881c3ce8ef193f644a26fc5daacfd59d23 | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 7025_UP | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 7425_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 1676_UP | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 7440_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 7472_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 7325_DN | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 2625_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 2062_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 4831_DN | |
| Disease | migraine disorder, type 2 diabetes mellitus | 1.00e-03 | 60 | 23 | 2 | MONDO_0005148, MONDO_0005277 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 4.38e-03 | 127 | 23 | 2 | EFO_0008595, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGKWDHVRQLVPRRD | 601 | P12814 | |
| QGLVWDPHNRRRQVL | 751 | Q6L9W6 | |
| QQDRPGRWEHRTCRQ | 196 | Q9HC96 | |
| GAWTLHEDPRQNRGG | 361 | O15484 | |
| DQGPDWERGFHRINI | 166 | P12644 | |
| DLPQLIGNHWQSRRR | 66 | Q7Z7B7 | |
| VRRLEWLQQHGGEPA | 126 | Q9BU89 | |
| PQQWHLNNRRSPGRD | 151 | Q16549 | |
| GQILDHRRPWEEGNR | 426 | P23677 | |
| AHRLQIEAWDGGRPR | 261 | Q6V1P9 | |
| EAARGQQPHQGLWRR | 6 | Q8NHH9 | |
| RGLQLISRWHNQGLP | 2491 | Q0VDD8 | |
| WLQRQDRHGAGEPKA | 316 | Q05932 | |
| WDHRIQAQGQRERRP | 766 | Q9NRM1 | |
| KAWRDGRGAHQNIIP | 266 | O14556 | |
| LPQQVNLTDGRWHRV | 136 | P25940 | |
| QRRLVEGNPNWLQGE | 121 | Q9BQI9 | |
| SRHWGAPQQREGRQQ | 186 | Q9Y5Y5 | |
| QRSQRRAPHLWGQPV | 391 | Q7Z6J9 | |
| GLWGPVHELGRNQQR | 751 | Q9Y4C2 | |
| RCNNEQWGLRHPQIL | 1291 | Q5VVP1 | |
| ERGQRSGRHGKPWEQ | 91 | Q96CK0 | |
| LPRNGDQWHEIRQGR | 516 | P30291 | |
| RGQLREGWRDSHQPI | 166 | Q9UKF7 | |
| PRGGRDWGEHNQRLE | 841 | Q14151 | |
| QWRQIENGESGRERP | 81 | P51784 | |
| QEWERGREPAAHQRG | 271 | Q5JTD7 |